Likewise, for GC, known driver mutations associated with GC tumorigenesis (TP53, ERBB2, PIK3CA, or RNF43) were identified in half of the GC samples (50%, 10/20; p = 0.0002) (Table 3). The gene discussed is ERBB2; the disease is gastric cancer.